Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Curis Earns $8 Million Milestone As NDA Accepted By FDA
Seeking Alpha
Thursday, November 10, 2011 - 1:08pm
tags:
Curis, milestone payments, FDA, basal cell carcinoma, Genentech, vismodegib
BDSI starting drug study
Bizjournals.com
Thursday, November 10, 2011 - 1:07pm
tags:
BioDelivery Sciences, BEMA Buprenorphine/Naloxone, drug abuse
Market Crash = Biotech Carnage
Motley Fool
Thursday, November 10, 2011 - 1:05pm
tags:
biotech, Zalicus, Complete Genomics, Pacific Biosciences, Illumina, Arena, Vivus
Drug Targeting Fat Cells Caused Significant Weight Loss in Monkeys; Human Trials to Begin Soon
WSJ Online
Thursday, November 10, 2011 - 12:31pm
tags:
obesity, fat cells, adipotide
What Bill Gates Says About Drug Companies
Forbes
Thursday, November 10, 2011 - 12:24pm
tags:
Bill Gates, GSK, vaccines, philanthropy, Merck, Sanofi
U.S. court allows class action suit against Amgen
Reuters
Wednesday, November 9, 2011 - 12:08pm
tags:
Class Action Lawsuit, Amgen
FDA gives priority to Roche skin cancer drug vismodegib
Pharma Times, UK
Wednesday, November 9, 2011 - 12:07pm
tags:
Roche, vismodegib, FDA, skin cancer, basal cell carcinoma, hedgehog pathway inhibitor
Antibiotics overprescribed for children: study
Reuters
Wednesday, November 9, 2011 - 11:57am
tags:
antibiotics, pediatrics
Glaxo Facing Mediation Push to Resolve Remaining Lawsuits Over Avandia
Bloomberg
Wednesday, November 9, 2011 - 11:56am
tags:
Avandia, GSK, diabetes
No Scrips: Doctor Boycotts Novartis Over Job Cuts
Pharmalot
Wednesday, November 9, 2011 - 11:55am
tags:
Novartis, boycotts, layoffs, physicians
AMRI Announces Collaboration Agreement with Lilly for In sourced Chemistry Services
CP Wire
Wednesday, November 9, 2011 - 11:42am
tags:
AMRI, Eli Lilly, in-sourcing
Merck & Co launches long-acting birth control implant Nexplanon
Yahoo/AP
Wednesday, November 9, 2011 - 11:33am
tags:
Merck, birth control, Nexplanon, contraceptives
Amarin CEO Refuses to Discuss Drug Patent Issues Killing His Stock Price
TheStreet.com
Wednesday, November 9, 2011 - 9:13am
tags:
Amarin, Joe Zakrzewski, patents, AMR101
Isis Pharma posts larger 3Q loss; shares fall
Yahoo/AP
Wednesday, November 9, 2011 - 9:11am
tags:
earnings, Isis Pharmaceuticals
Salix to buy Oceana Therapeutics for $300 mln
Reuters
Tuesday, November 8, 2011 - 7:26pm
tags:
Salix, Oceana Therapeutics, M&A
Insights from Amylin CEO on Split with Lilly
CNBC
Tuesday, November 8, 2011 - 7:24pm
tags:
Amylin, Eli Lilly, diabetes, Daniel Bradbury
IPO Preview: NewLink Genetics
Seeking Alpha
Tuesday, November 8, 2011 - 7:22pm
tags:
NewLink Genetics, IPO, HyperAcute Pancreas, HyperAcute Lung
Pfizer: Strong And Safe With Catalysts
Pfizer: Strong And Safe With Catalysts
Tuesday, November 8, 2011 - 7:19pm
tags:
Pfizer, JNJ, Abbott Laboratories
Pfizer, Ranbaxy Sued By 11 Pharmacies Over Lipitor Prices
Bloomberg
Tuesday, November 8, 2011 - 7:18pm
tags:
Pfizer, Ranbaxy, Lipitor, generics
Study: Deal terms getting richer as pharmas stockpile antibody tech
Fierce Biotech
Tuesday, November 8, 2011 - 11:06am
tags:
antibodies, autoimmune disease, CNS, Roche, AstraZeneca, Bristol-Myers Squibb, Novartis, Pfizer, Merck, mAb

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.